Feed Preview

Fast Growing

Breast Cancer Triple-N

Breast Cancer Triple-N diagram by MossStudio, Shutterstock
MossStudio, Shutterstock

Breast cancer cells have receptors for estrogen, progesterone, HER2 receptors (also called ERBB2). Triple-negative breast cancers do not have any of these receptors. Here are the latest discoveries pertaining to triple-negative breast cancers.

Top 20 most recent papers
May 20, 2020
ReviewOpen Access

Novel antibody-drug conjugates for triple negative breast cancer

Therapeutic Advances in Medical Oncology
Aiko NagayamaAditya Bardia
May 20, 2020
Open Access

Analysis of the autoimmune regulator (AIRE) gene variant rs2075876 (G/A) association with breast cancer susceptibility

Journal of Clinical Laboratory Analysis
Manal S Fawzy, Eman A Toraih
May 20, 2020

Combination of sirtuin 3 and hyperoxia diminishes tumorigenic properties of MDA-MB-231 cells

Life Sciences
Iva I PodgorskiSandra Sobočanec
May 24, 2020
Open Access

Two Sides to the Same Coin-Cytotoxicity vs. Potential Metastatic Activity of AgNPs Relative to Triple-Negative Human Breast Cancer MDA-MB-436 Cells

Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry
Magdalena Matysiak-KucharekLucyna Kapka-Skrzypczak
May 23, 2020
Open Access

Carbonic Anhydrase-IX Guided Albumin Nanoparticles for Hypoxia-mediated Triple-Negative Breast Cancer Cell Killing and Imaging of Patient-derived Tumor

Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry
Katyayani TatipartiArun K Iyer
May 22, 2020

Patient demographics and management challenges in an Irish symptomatic breast cancer unit

Irish Journal of Medical Science
Zac L CoynePatrick G Morris
May 23, 2020

EGFR Targeted Paclitaxel and Piperine Co-loaded Liposomes for the Treatment of Triple Negative Breast Cancer

AAPS PharmSciTech
Ankita Sanjay BurandeMadaswamy S Muthu

See more papers from this feed

Related Feeds

Breast Cancer: BRCA1 & BRCA2

Mutations involving BRCA1, found on chromosome 17, and BRCA2, found on chromosome 13, increase the risk for specific cancers, such as breast cancer. Discover the last research on breast cancer BRCA1 and BRCA2 here.

Breast Cancer: Chemo-Resistance

Some cancers are difficult to treat and aggressive including the "triple-negative" breast cancer. This type of cancer is chemoresistant even before chemotherapy begins. Here are the latest discoveries chemo-resistance in breast cancer.

Breast Cancer: Risk Factors

Breast cancer is a multifactorial disease that is influenced by both environmental and genetic factors. Discover the latest research on the environmental and genetic risk factors for breast cancer here.

Breast Cancer: Therapeutic Approaches

Several different therapeutic approaches are used to treat breast cancer. These include chemotherapy, hormonal therapy, targeted therapy, and Immunotherapy. Discover the latest research on breast cancer therapeutic approaches here.

Breast Invasive Carcinoma

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Breast Tumorigenesis

Breast tumorigenesis involves the production or formation of tumor(s) in breast tissue. Discover the latest research on breast tumorigenesis here.

Carcinoma, Lobular

Lobular carcinoma is an invasive type of breast cancer in which lobules, areas of the breast that produce milk, undergo malignant transformation. Here is the latest research.

Hereditary Breast & Ovarian Cancer

Hereditary breast and ovarian cancer due to mutations in the brca1 and brca2 genes is the most common cause of hereditary forms of both breast and ovarian cancer. Here are the latest discoveries pertaining to these cancers.

Inflammatory Breast Neoplasms

Inflammatory breast cancer is a rare disease characterized by edema and redness of the breast. This is caused by metastatic breast cancer cells blocking lymphatic vessels. Discover the latest research on Inflammatory breast cancer here.

© 2020 Meta ULC. All rights reserved